These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16875814)

  • 1. Homo-cysteinyl peptide inhibitors of the L1 metallo-beta-lactamase, and SAR as determined by combinatorial library synthesis.
    Sun Q; Law A; Crowder MW; Geysen HM
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5169-75. PubMed ID: 16875814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slow-binding human serine racemase inhibitors from high-throughput screening of combinatorial libraries.
    Dixon SM; Li P; Liu R; Wolosker H; Lam KS; Kurth MJ; Toney MD
    J Med Chem; 2006 Apr; 49(8):2388-97. PubMed ID: 16610782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A specific peptide inhibitor of the class B metallo-beta-lactamase L-1 from Stenotrophomonas maltophilia identified using phage display.
    Sanschagrin F; Levesque RC
    J Antimicrob Chemother; 2005 Feb; 55(2):252-5. PubMed ID: 15659541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition studies on the metallo-beta-lactamase L1 from Stenotrophomonas maltophilia.
    Yang KW; Crowder MW
    Arch Biochem Biophys; 1999 Aug; 368(1):1-6. PubMed ID: 10415104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteinyl peptide inhibitors of Bacillus cereus zinc beta-lactamase.
    Bounaga S; Galleni M; Laws AP; Page MI
    Bioorg Med Chem; 2001 Feb; 9(2):503-10. PubMed ID: 11249142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bulgecin A: a novel inhibitor of binuclear metallo-beta-lactamases.
    Simm AM; Loveridge EJ; Crosby J; Avison MB; Walsh TR; Bennett PM
    Biochem J; 2005 May; 387(Pt 3):585-90. PubMed ID: 15569001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insights into the design of inhibitors for the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia.
    Nauton L; Kahn R; Garau G; Hernandez JF; Dideberg O
    J Mol Biol; 2008 Jan; 375(1):257-69. PubMed ID: 17999929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-ketophosphonates as beta-lactamase inhibitors: Intramolecular cooperativity between the hydrophobic subsites of a class D beta-lactamase.
    Perumal SK; Adediran SA; Pratt RF
    Bioorg Med Chem; 2008 Jul; 16(14):6987-94. PubMed ID: 18572409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic combinatorial mass spectrometry leads to metallo-beta-lactamase inhibitors.
    Liénard BM; Hüting R; Lassaux P; Galleni M; Frère JM; Schofield CJ
    J Med Chem; 2008 Feb; 51(3):684-8. PubMed ID: 18205296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of 3-(carboxymethylidene)- and 3-(carboxymethyl)penicillinates as inhibitors of beta-lactamase.
    Buynak JD; Ghadachanda VR; Vogeti L; Zhang H; Chen H
    J Org Chem; 2005 May; 70(11):4510-3. PubMed ID: 15903334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of the FEZ-1 metallo-beta-lactamase.
    Liénard BM; Horsfall LE; Galleni M; Frère JM; Schofield CJ
    Bioorg Med Chem Lett; 2007 Feb; 17(4):964-8. PubMed ID: 17157014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irreversible inhibition of metallo-beta-lactamase (IMP-1) by 3-(3-mercaptopropionylsulfanyl)propionic acid pentafluorophenyl ester.
    Kurosaki H; Yamaguchi Y; Higashi T; Soga K; Matsueda S; Yumoto H; Misumi S; Yamagata Y; Arakawa Y; Goto M
    Angew Chem Int Ed Engl; 2005 Jun; 44(25):3861-4. PubMed ID: 15892033
    [No Abstract]   [Full Text] [Related]  

  • 13. A highly potent and selective PKCalpha inhibitor generated via combinatorial modification of a peptide scaffold.
    Lee JH; Nandy SK; Lawrence DS
    J Am Chem Soc; 2004 Mar; 126(11):3394-5. PubMed ID: 15025445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New leads of metallo-beta-lactamase inhibitors from structure-based pharmacophore design.
    Olsen L; Jost S; Adolph HW; Pettersson I; Hemmingsen L; Jørgensen FS
    Bioorg Med Chem; 2006 Apr; 14(8):2627-35. PubMed ID: 16378729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibition of metallo-beta-lactamase by thioxo-cephalosporin derivatives.
    Tsang WY; Dhanda A; Schofield CJ; Frère JM; Galleni M; Page MI
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1737-9. PubMed ID: 15026061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244.
    Thomson JM; Distler AM; Bonomo RA
    Biochemistry; 2007 Oct; 46(40):11361-8. PubMed ID: 17848099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using surface plasmon resonance to directly measure slow binding of low-molecular mass inhibitors to a VanX chip.
    Chang YP; Tseng MJ; Chu YH
    Anal Biochem; 2006 Dec; 359(1):63-71. PubMed ID: 16965759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying selective protein tyrosine phosphatase substrates and inhibitors from a fluorogenic, combinatorial peptide library.
    Mitra S; Barrios AM
    Chembiochem; 2008 May; 9(8):1216-9. PubMed ID: 18412190
    [No Abstract]   [Full Text] [Related]  

  • 19. The one-bead two-compound assay for solid phase screening of combinatorial libraries.
    Meldal M
    Biopolymers; 2002; 66(2):93-100. PubMed ID: 12325159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combinatorial approach to minimal peptide models of a metalloprotein active site.
    Namuswe F; Goldberg DP
    Chem Commun (Camb); 2006 Jun; (22):2326-8. PubMed ID: 16733568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.